ARCHIVES

Interferon “Hysteria” Prompts ASCO To Warn Against Expecting Immediate Benefits

This article is from The Cancer Letter archive.

Vol. 06 No. 25 | June 20, 1980

Download PDF Visit The Full Archive

Related Articles

Two Second-Line CML Drugs Work Front-Line, Studies Find

January 29, 2010

Also in this 8-page issue: David Hohn elected board chairman of the National Comprehensive Cancer Network.

March 26, 2004

Larry Norton Is President-Elect Of ASCO; Rauscher Is Cancer Research Editor-In-Chief.

March 3, 2000

ASCO Ends Early Distribution Of Abstracts To Halt “ASCO Effect” On Stock Market

January 24, 2003

Healy ‘Concerned’ About NCI Budget; ‘Definite Erosion’

May 3, 1991

Group Chairman Present A Counter-Proposal To NCI Committee

June 12, 1998